Mark Hagler
Advertisement
Articles by Mark Hagler
Advertisement
Latest Updated Articles
COVID-19: Sun Pharmaceuticals business updateApril 23rd 2020
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Tinlarebant NDA submission completed for Stargardt disease type 1, targeting first approved therapy
2
Recognizing biomarkers of Alzheimer Disease using OCTA
3
Midyear cataract check-in: What 2026 has brought to the OR and beyond
4
FDA accepts Outlook Therapeutics' resubmitted BLA for ONS-5010 (LYTENAVA)
5